Recommended Additional Medication
For this 70-year-old man with recurrent fear, anxiety, and negative thoughts in the context of chronic axonal sensory neuropathy, add duloxetine as the optimal medication—it simultaneously addresses both the anxiety symptoms and the neuropathic pain component. 1
Rationale for Duloxetine
Duloxetine is a selective serotonin-norepinephrine reuptake inhibitor (SSNRI) that serves dual purposes in this clinical scenario:
For Anxiety Management
- First-line agent for generalized anxiety disorder with proven efficacy in older adults 2
- Recent 2025 meta-analysis demonstrates antidepressants (particularly SSRIs/SNRIs) are more effective than placebo for reducing anxiety symptoms in older adults (SMD -1.19), with moderate certainty of evidence 2
- Duloxetine specifically has established efficacy for both major depression and generalized anxiety disorder 1
For Neuropathic Pain (Sensory Neuropathy)
- First-line therapy for neuropathic pain per Mayo Clinic guidelines 1
- Demonstrated consistent efficacy in painful diabetic peripheral neuropathy with sustained effectiveness for 1 year 1
- Works in painful polyneuropathies of various origins 3
Dosing Protocol for Older Adults
Start conservatively given his age:
- Begin with 30 mg once daily for 1 week to minimize nausea (most common side effect) 1
- Increase to 60 mg once daily after the first week 1
- Maximum dose: 60 mg twice daily if needed, though 60 mg once daily is often equally effective 1
- Allow 4 weeks for adequate trial at therapeutic dose 1
Safety Considerations in This 70-Year-Old
Favorable safety profile:
- Does not produce clinically important electrocardiographic changes or blood pressure alterations 1
- Aminotransferase monitoring is unnecessary 1
- Superior tolerability compared to tricyclic antidepressants, which carry cardiac risks in older adults 1
Alternative If Duloxetine Fails or Is Not Tolerated
If inadequate response after 4 weeks at 60 mg daily:
Add pregabalin (gabapentinoid) to duloxetine for combination therapy 1
Switch to sertraline or escitalopram (SSRIs) if SSNRI not tolerated 5
- 2024 algorithm for GAD in older adults recommends these as first-line alternatives 5
Critical Pitfalls to Avoid
Do NOT use benzodiazepines despite their anxiolytic effects:
- Evidence for efficacy and safety in older adults is very weak with high risk of bias 2
- 2024 geriatric anxiety algorithm recommends caution with benzodiazepines for acute treatment 5
- Increased fall risk, cognitive impairment, and dependence in this age group
Avoid tricyclic antidepressants (nortriptyline, desipramine):
- Although effective for neuropathic pain, they carry significant cardiac toxicity risk 1
- Require screening ECG in patients over 40 years 1
- Less favorable adverse-effect profile in older adults 4